- Home
- PLYA vs VIR Comparison
PLYA vs VIR Comparison
Compare PLYA & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYA
- VIR
- Stock Information
- Founded
- PLYA 2006
- VIR 2016
- Country
- PLYA Netherlands
- VIR United States
- Employees
- PLYA N/A
- VIR N/A
- Industry
- PLYA Hotels/Resorts
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- PLYA Consumer Discretionary
- VIR Health Care
- Exchange
- PLYA Nasdaq
- VIR Nasdaq
- Market Cap
- PLYA 1.2B
- VIR 1.0B
- IPO Year
- PLYA N/A
- VIR 2019
- Fundamental
- Price
- PLYA $9.72
- VIR $7.12
- Analyst Decision
- PLYA Strong Buy
- VIR Buy
- Analyst Count
- PLYA 5
- VIR 5
- Target Price
- PLYA $11.40
- VIR $36.40
- AVG Volume (30 Days)
- PLYA 1.2M
- VIR 1.6M
- Earning Date
- PLYA 11-06-2024
- VIR 10-31-2024
- Dividend Yield
- PLYA N/A
- VIR N/A
- EPS Growth
- PLYA 106.66
- VIR N/A
- EPS
- PLYA 0.49
- VIR N/A
- Revenue
- PLYA $949,669,000.00
- VIR $78,618,000.00
- Revenue This Year
- PLYA N/A
- VIR N/A
- Revenue Next Year
- PLYA $2.21
- VIR N/A
- P/E Ratio
- PLYA $19.85
- VIR N/A
- Revenue Growth
- PLYA 0.71
- VIR N/A
- 52 Week Low
- PLYA $6.95
- VIR $6.56
- 52 Week High
- PLYA $10.13
- VIR $13.09
- Technical
- Relative Strength Index (RSI)
- PLYA 69.35
- VIR 38.72
- Support Level
- PLYA $9.25
- VIR $6.56
- Resistance Level
- PLYA $10.13
- VIR $10.13
- Average True Range (ATR)
- PLYA 0.25
- VIR 0.56
- MACD
- PLYA -0.01
- VIR -0.29
- Stochastic Oscillator
- PLYA 73.55
- VIR 14.43
About PLYA Playa Hotels & Resorts N.V.
Playa Hotels & Resorts NV acts as an owner, operator, and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. The company's segments are Yucatan Peninsula, Pacific Coast, Dominican Republic, and Jamaica. It generates a majority of its revenue from the Yucatan Peninsula segment. Its brand profile consists of HYATT ZIVA, HYATT ZILARA, Hilton, JEWEL RESORTS, and others.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.